Edaravone inhibits collagen-induced arthritis possibly through suppression of nuclear factor-kappa B
Authors:
- 1 January 2008
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 45 (2) , 463-469
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Edaravone inhibits the disease activity in rheumatoid arthritisJournal of Clinical Pharmacy and Therapeutics, 2006
- Edaravone inhibits rheumatoid synovial cell proliferation and migrationFree Radical Research, 2006
- Tempol Reduces the Activation of Nuclear Factor-κB in Acute InflammationFree Radical Research, 2004
- Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in ratsArthritis Research & Therapy, 2003
- Oxidant/Antioxidant Status of the Erythrocytes from Patients with Rheumatoid ArthritisClinical Rheumatology, 2000
- Intravenous administration of superoxide dismutase entrapped in long circulating liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986